JoAnne M. Foody

Esperion Therapeutics (United States) — United States

Medicine · Health Sciences

49h-index13.8kcitations590works24.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(140), Acute Myocardial Infarction Research(81), Health Systems, Economic Evaluations, Quality of Life(70), Diabetes, Cardiovascular Risks, and Lipoproteins(65), Blood Pressure and Hypertension Studies(55)

Publications590 total

Characteristics and Outcomes for Hispanic/Latinx Participants With Statin Intolerance Receiving Bempedoic Acid
Journal of the American College of Cardiology·2024· 2 cited
Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials
Cardiovascular Research·2024· 47 citedOpen Access
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
JAMA·2023· 123 citedOpen Access
2022 ACC Health Policy Statement on Career Flexibility in Cardiology
Journal of the American College of Cardiology·2022· 19 cited
Updated ACCF/AHA Guidelines on the Management of STEMI: Implications for Antiplatelet Therapy (Part II of II)
The Medical Roundtable Cardiovascular Edition·2021
Efficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation (SmartADHERE) a randomized clinical trial
American Heart Journal·2021· 19 citedOpen Access
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)
Circulation·2020· 62 citedOpen Access
Cardiovascular Disease in Women
DeckerMed Medicine·2019· 1 cited
Cardiovascular Disease in Women
DeckerMed Family Medicine·2019· 1 cited
Abstract 23: Patient Level Prediction Models Developed With Large Observational Databases Outperformed Existing Clinical Prediction Scores For Stratifying Bleeding Risk In Patients With Atrial Fibrillation
Circulation Cardiovascular Quality and Outcomes·2019
EFFICACY OF A CENTRALIZED, BLENDED ELECTRONIC, AND HUMAN INTERVENTION TO IMPROVE DOAC ADHERENCE: THE SMARTADHERE TRIAL
Journal of the American College of Cardiology·2019
Novel Risk Factors for Coronary Artery Disease Prevention: Fact or Fiction?
The Medical Roundtable Cardiovascular Edition·2018
Influence of age on the pharmacokinetics, pharmacodynamics, efficacy, and safety of rivaroxaban
Current Medical Research and Opinion·2018· 10 citedOpen Access
American Geriatrics Society Beers Criteria and Anticoagulant Use in Older Adults With Renal Impairment
Kidney International Reports·2017Open Access
Major Cardiovascular Events in Patients with Gout and Associated Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating a Xanthine Oxidase Inhibitor.
PubMed·2017· 43 citedOpen Access
A comparison of the attainment of guideline-recommended LDL-C lowering with statin and ezetimibe+statin therapies
Atherosclerosis·2017
A Comparison of the Attainment of Guideline-Recommended LDL-C Lowering With Statin and Ezetimibe+Statin Therapies
Journal of clinical lipidology·2017
Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians
Clinical Interventions in Aging·2017· 13 citedOpen Access
Patterns and predictors of lipid‐lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large <scp>US</scp> managed‐care population
Clinical Cardiology·2016· 43 citedOpen Access
GW27-e0459 Attainment of acc/aha recommended ldl-c lowering with statin and ezetimibe+statin therapies
Journal of the American College of Cardiology·2016
page 1 of 30Next →

Frequent Co-authors

Harlan M. Krumholz(27), Frederick A. Masoudi(14), Edward P. Havranek(14), Yongfei Wang(10), Saif S. Rathore(8), Stephan D. Fihn(5), John A. Spertus(5), Dennis T. Ko(5), Julius M. Gardin(4), Jonathan Abrams(4), Kathleen Berra(4), James C. Blankenship(4), Apostolos P. Dallas(4), Pamela S. Douglas(4), Thomas C. Gerber(4), Alan L. Hinderliter(4), Spencer B. King(4), Paul Kligfield(4), Raymond Y. Kwong(4), Michael J. Lim(4)